KEGG: sce:YDL180W
STRING: 4932.YDL180W
YDL180W is a gene in Saccharomyces cerevisiae (budding yeast) that has been studied in genetic interaction networks. While the gene itself has limited Gene Ontology (GO) annotations for biological processes and molecular functions, it does have cellular component annotations . Antibodies against YDL180W are valuable research tools for studying protein localization, expression levels, and interactions within cellular pathways. The development of specific antibodies enables researchers to track this protein in various experimental conditions, particularly when investigating genetic interactions with other genes such as YET2 .
According to the BioGRID database, YDL180W has Gene Ontology (GO) annotations for cellular components, though specific components aren't detailed in the search results. The protein appears to have subcellular localization data that researchers would target with antibody-based detection methods . Understanding these cellular components is essential for designing properly controlled immunolocalization experiments.
YDL180W demonstrates a significant negative genetic interaction with YET2, with an SGA score of -0.2666 (P-value = 0.002416) . This negative genetic interaction indicates that mutations or deletions in both genes result in a more severe fitness defect than would be expected from the individual mutations alone, particularly affecting colony size in yeast . Antibodies can help study these interactions through co-immunoprecipitation experiments, proximity ligation assays, or immunofluorescence co-localization studies to determine if and where these gene products physically interact.
While specific fixation protocols for YDL180W are not detailed in the search results, researchers should apply principles similar to those used with other yeast proteins. For yeast cells, a combination approach is recommended: start with 3.7% formaldehyde fixation for 30-60 minutes at room temperature, followed by cell wall digestion with zymolyase or lyticase. This two-step process preserves protein epitopes while allowing antibody penetration through the yeast cell wall. When optimizing fixation conditions, perform parallel experiments comparing different fixation times (30, 45, and 60 minutes) to identify the protocol that maximizes signal-to-noise ratio without compromising cellular morphology.
Validation should follow a multi-step approach similar to that used for the APP antibody in result . This includes: (1) Western blotting with both wild-type and YDL180W knockout strains to confirm absence of signal in knockout samples; (2) immunoprecipitation followed by mass spectrometry to confirm the antibody pulls down YDL180W; (3) immunofluorescence comparing localization patterns with GFP-tagged YDL180W; and (4) peptide competition assays to demonstrate binding specificity . Advanced researchers should additionally perform cross-reactivity tests against homologous proteins in closely related yeast species.
While specific concentrations for YDL180W antibodies aren't provided in the search results, researchers should employ a systematic titration approach. For Western blotting, begin with dilutions ranging from 1:500 to 1:5000, while immunofluorescence typically requires more concentrated antibody solutions (1:100 to 1:500). For each new application or experimental condition, researchers should perform antibody titration experiments, plotting signal-to-noise ratio against antibody concentration to determine the optimal working concentration that maximizes specific signal while minimizing background.
Quantification of YDL180W expression should employ densitometry analysis using software such as ImageJ or similar tools. For proper normalization: (1) always include a loading control such as PGK1 or actin; (2) calculate the ratio of YDL180W signal to loading control signal; (3) normalize experimental samples to appropriate controls; (4) perform at least three biological replicates; and (5) apply statistical tests appropriate for the experimental design. Researchers should be aware that normalization methods may need to be adjusted based on experimental conditions and should be consistently applied across all samples within a study.
To distinguish specific signal from background: (1) always include negative controls (secondary antibody only, pre-immune serum, and ideally a YDL180W knockout strain); (2) compare staining patterns with GFP-tagged YDL180W expressing strains; (3) perform Z-stack imaging to confirm three-dimensional localization patterns; and (4) quantify fluorescence intensity in regions of interest compared to background regions. Advanced researchers should consider super-resolution microscopy techniques for more precise localization of YDL180W when studying its interactions with YET2 or other proteins.
For high-throughput screening approaches similar to those used in the genetic interaction studies , researchers should employ: (1) normalization methods to account for plate-to-plate variation; (2) Z-score calculations to identify significant hits; (3) appropriate multiple testing corrections such as Benjamini-Hochberg when analyzing large datasets; and (4) validation of hits using orthogonal methods. For genetic interaction studies specifically, use statistical frameworks similar to those applied in the global genetic interaction network study, which considered interactions significant if they had a p-value < 0.05 and appropriate SGA scores (> 0.16 for positive, < -0.12 for negative interactions) .
Researchers can implement time-course experiments using YDL180W antibodies to monitor protein expression, localization changes, and post-translational modifications under various stress conditions (oxidative stress, nutrient limitation, DNA damage). Design experiments that collect samples at multiple timepoints (0, 15, 30, 60, 120 minutes) after stress induction, then analyze using Western blotting, immunoprecipitation, and immunofluorescence microscopy. This approach can reveal whether YDL180W responds to specific stressors and potentially elucidate its functional role, particularly in relation to its negative genetic interaction with YET2 .
Researchers should implement a multi-faceted approach: (1) immunoprecipitate YDL180W using validated antibodies followed by mass spectrometry to identify potential modifications; (2) use phospho-specific antibodies in Western blotting if phosphorylation is suspected, similar to approaches used in phosphohistidine research ; (3) perform 2D gel electrophoresis to separate differently modified forms; and (4) use chemical treatments to remove specific modifications (phosphatases for phosphorylation, deubiquitinases for ubiquitination) to confirm their presence. X-ray crystallography approaches similar to those described in result can provide structural insights into how these modifications affect protein function.
Building on the negative genetic interaction identified between YDL180W and YET2 , researchers can use YDL180W antibodies to investigate the molecular mechanisms behind this interaction. Design experiments that: (1) examine protein expression levels in single and double mutants; (2) assess protein localization changes when interaction partners are deleted; (3) perform immunoprecipitation studies to identify physical interaction partners that might explain genetic interactions; and (4) use proximity labeling approaches similar to the APEX2-mediated proximity labeling mentioned in result to identify proteins in close proximity to YDL180W in living cells. These approaches can help elucidate how YDL180W contributes to cellular functions and why its interaction with YET2 affects colony size.
Non-specific binding can result from several factors: (1) insufficient blocking - increase blocking agent concentration to 5% and extend blocking time to 1-2 hours; (2) excessive antibody concentration - perform titration experiments to determine optimal concentration; (3) cross-reactivity with homologous proteins - pre-absorb antibody with knockout cell lysates; and (4) improper washing - increase wash duration and volume. For Western blotting specifically, add 0.1% SDS to wash buffers to reduce hydrophobic interactions, and for immunofluorescence, include 0.1-0.3% Triton X-100 in blocking solutions to reduce membrane-associated background.
When signals are weak or absent: (1) verify protein expression using alternative methods such as RNA analysis or epitope tagging; (2) test alternative epitope retrieval methods for fixed samples; (3) reduce stringency of wash conditions; (4) increase antibody concentration or incubation time; and (5) try alternative detection systems with higher sensitivity. For yeast specifically, ensure proper cell wall digestion, as inadequate digestion is a common cause of poor antibody penetration. Consider using recombinant antibody formats similar to those mentioned for the APP antibody if traditional antibodies provide inconsistent results.
For co-localization studies of YDL180W and interactors like YET2: (1) ensure antibodies are raised in different host species to allow simultaneous detection; (2) verify that secondary antibodies don't cross-react; (3) include appropriate controls for bleed-through in fluorescence channels; (4) use sequential rather than simultaneous antibody incubations if cross-reactivity occurs; and (5) employ quantitative co-localization analysis using Pearson's or Mander's coefficients rather than relying on visual assessment alone. For advanced studies, consider super-resolution microscopy or proximity ligation assays to confirm interactions at the nanometer scale.
Recombinant antibody technologies, similar to those used for the APP antibody , offer several advantages for YDL180W research: (1) enhanced batch-to-batch consistency, eliminating the variability of polyclonal antibodies; (2) ability to engineer binding properties for specific applications; (3) potential for generating fragment antibodies that can penetrate yeast cell walls more efficiently; and (4) capacity for developing bi-specific antibodies that could simultaneously target YDL180W and interacting partners like YET2. Researchers should consider testing both traditional monoclonal antibodies and newer recombinant formats to determine which provides optimal performance for their specific application.
For live-cell imaging of YDL180W: (1) evaluate cell-permeable fluorescent nanobodies derived from conventional YDL180W antibodies; (2) consider split-GFP complementation systems where one fragment is fused to an antibody fragment and the other to YDL180W; (3) assess intrabodies (intracellular antibodies) expressed from plasmids directly within yeast cells; and (4) explore newer techniques like specific protein labeling using SNAP-tag or Halo-tag systems conjugated to YDL180W-specific binding proteins. These approaches must be carefully validated against traditional fixed-cell immunofluorescence to ensure the observed patterns accurately reflect true protein localization.